Health Economics &
Real-World Evidence Solutions

Utilizing our extensive experience in gathering data from diverse sources to improve healthcare decisions

SIRO integrates rigorous systematic review, real-world evidence, and health economic expertise to support HTA submissions, market access strategies, and publication programmes.

Differentiators

Expertise in Real-World Data Collection and Analysis

Connects with investigators and engagements with hospitals help us generate prospective real-world data and accessing healthcare data for retrospective analysis

Specialised writers

Dedicated writers for real world evidence and outcomes research publications expertise in value communications

Competence exhibition at global platforms

Regular presentations at ISMPP/ISPOR, webinars and workshops

Analysts specially trained to cater different needs

Analysts with public health and epidemiology background trained on regression analysis, survival analysis, meta-analysis and pharmacoeconomic modelling

Delivering Cutting-Edge Solutions and Services Across all HEOR Domains

Evidence Generation

Systematic Literature Reviews (SLR)
Targeted Literature Reviews (TLR)
Rapid reviews for time-sensitive evidence needs
Living reviews for update-ready evidence generation
Structured search strategy development aligned to PRISMA principles

Systematic Literature Review and Targeted Literature Review

Search Strategy Development

Literature Search

Gap Analysis

Meta-analysis

SLR Report

SLR Manuscript

Descriptive Data Analysis

We meticulously analyze and summarize complex data sets, whether derived from study findings or retrospective data sources such as charts, Patient-Reported Outcomes (PROs), and Electronic Health Records (EHRs)

Case Studies

As a part of market access strategy, client wanted to defend their product pipeline for a particular disease area

Effectively communicate information to external stakeholders, read more

Client was facing challenges related to the market access of their pain management portfolio

Client wanted to identify physicians'/patients' perceptions, read more

Pharma giant wanted to launch their new Drug to 9 different countries of Asia-Pacific market

Their global market access team wanted to decide market access read more

Learn More

Health Economics & Real-World Evidence Solutions